Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Laure Chauvenet"'
Autor:
Françoise Laroche, Serge Perrot, Terkia Medkour, Paul-Henri Cottu, Jean-Yves Pierga, Jean-Pierre Lotz, Karine Beerblock, Christophe Tournigand, Laure Chauvenet, Didier Bouhassira, Joël Coste
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187165 (2017)
Women with hormone-dependent breast cancer are treated with aromatase inhibitors (AI) to slow disease progression by decreasing estrogen levels. However, AI have adverse effects, including pain, with potentially serious impact on quality of life (QOL
Externí odkaz:
https://doaj.org/article/a108ec18f141430386c35cf1c3b94dcb
Autor:
George Emile, Jérôme Alexandre, Jean-Marie Tigaud, Eric Pujade Lauraine, Jean Chidiac, Laure Chauvenet
Publikováno v:
Gynecologic Oncology. 129:459-462
Objective The objective of this study is to report the efficacy and tolerance of single agent bevacizumab (BEVA) in relapsing ovarian cancer patients treated in a single institution outside a clinical trial. Methods To receive single agent BEVA, pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ac9543abb380a28829b3098a392d5f
https://doi.org/10.1016/j.ygyno.2013.02.035
https://doi.org/10.1016/j.ygyno.2013.02.035
Autor:
Guillemette Laval, Blandine Marcelin-Benazech, Catherine Arvieux, Laure Chauvenet, Laure Copel, Aurélie Durand, Eric Francois, Martine Gabolde, Frédéric Guirimand, Pascale Mariani, Christine Rebischung, Vincent Servois, Eric Terrebonne
Publikováno v:
Médecine Palliative : Soins de Support - Accompagnement - Éthique. 11:S5-S24
Resume Cet article presente des recommandations de bonnes pratiques etablies par un groupe de travail pluridisciplinaire concernant l'indication et l'utilisation des differents moyens therapeutiques visant a lever l'occlusion ou en soulager les sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e689b19e67ed24e7f615487ec883a4d6
https://doi.org/10.1016/s1636-6522(12)70003-x
https://doi.org/10.1016/s1636-6522(12)70003-x
Autor:
Marie-Aude Lefrère-Belda, Caroline Rousseau, Laure Chauvenet, Pierre Combe, Hélène Blons, Eric Pujade-Lauraine, Stéphane Oudard
Publikováno v:
Investigational new drugs. 33(6)
Low-grade serous ovarian adenocarcinomas (LGSOC) make up approximately 10 % of serous ovarian carcinomas. While rarely aggressive, this slow-growing tumor is well known to respond poorly to chemotherapy. Specific treatments for this ovarian subtype a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9bc61f401962e1c083a31c06259ec7
https://pubmed.ncbi.nlm.nih.gov/26490654
https://pubmed.ncbi.nlm.nih.gov/26490654
Autor:
Karine Beerblock, Joël Coste, Jean-Yves Pierga, Serge Perrot, Paul-Henri Cottu, Christophe Tournigand, Laure Chauvenet, Françoise Laroche, Didier Bouhassira, Terkia Medkour, Jean-Pierre Lotz
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187165 (2017)
PLoS ONE
PLoS ONE
Women with hormone-dependent breast cancer are treated with aromatase inhibitors (AI) to slow disease progression by decreasing estrogen levels. However, AI have adverse effects, including pain, with potentially serious impact on quality of life (QOL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772739a11ffa85259a0c9d9930c6705e
https://doi.org/10.1371/journal.pone.0187165
https://doi.org/10.1371/journal.pone.0187165
Autor:
Catherine Arvieux, Frédéric Guirimand, Guillemette Laval, Eric Terrebonne, Martine Gabolde, Aurélie Durand, Laure Chauvenet, Laure Copel, Blandine Marcelin-Benazech, Vincent Servois, Pascale Mariani, Eric Francois, Christine Rebischung
Publikováno v:
Journal of pain and symptom management. 48(1)
This article reports on the clinical practice guidelines developed by a multidisciplinary group working on the indications and uses of the various available treatment options for relieving intestinal obstruction or its symptoms in patients with perit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc94241c1ca618e7ea13ea6994f94a6b
https://pubmed.ncbi.nlm.nih.gov/25128607
https://pubmed.ncbi.nlm.nih.gov/25128607
Autor:
Pascale Mariani, Estelle Botton, Alain Landau, Joëlle Blumberg, D. Mayeur, Robert Herve, Daniela Lebrun-Jezekova, Pascal Maisonobe, Olivier Beatrix, Laure Chauvenet
Publikováno v:
Obstetrical & Gynecological Survey. 68:437-438
Purpose To investigate the somatostatin analog lanreotide as symptomatic treatment for inoperable bowel obstruction due to peritoneal carcinomatosis. Patients and Methods In all, 80 patients with peritoneal carcinomatosis, inoperable malignant digest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d970cd70f1149bec9812e93dc7518c
https://doi.org/10.1097/ogx.0b013e318294c9b8
https://doi.org/10.1097/ogx.0b013e318294c9b8
Autor:
Christophe Tournigand, Paul Cottu, Jean-Pierre Lotz, Karine Beerblock, Serge Perrot, F Borderie, Laure Chauvenet, T. Medkour, Joël Coste, Frédéric Batteux, Jean-Yves Pierga, D Boussahira, Xavier Declèves, Françoise Laroche
Publikováno v:
ResearcherID
569 Background: Pain is frequent during Aromatase Inhibitors (AIs) treatment for breast cancer and several pain syndromes have been reported but not precisely defined. We developed a prospective multicentre study aiming at classifying AIs-related pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97f0c047db660331702db789de56619
https://doi.org/10.1200/jco.2013.31.15_suppl.569
https://doi.org/10.1200/jco.2013.31.15_suppl.569
Autor:
Jerome Rossert, Laure Chauvenet, Josee Audouin, Marie-Helene Horellou, Alain Bernadou, Michelle Ciaudo, Remy Favier, Samama M
Publikováno v:
Leukemialymphoma. 19(5-6)
A patient with high fever, loss of weight and profound pancytopenia is reported. Peripheral T-cell lymphoma with hemophagocytosis was diagnosed. Bone marrow was the only localisation of the lymphoma. At presentation there were (i) a coagulopathy cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a48718ec177f7ce4f10c9a8e710245
https://pubmed.ncbi.nlm.nih.gov/8590855
https://pubmed.ncbi.nlm.nih.gov/8590855
Publikováno v:
Journal of Clinical Oncology. 29:242-242
242 Background: Somatostatin analogues in previous open label studies improved symptoms due to bowel obstruction in patients with peritoneal carcinomatosis. This study assessed the efficacy and safety of lanreotide microparticles 30 mg as treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a7826cb7ddab8438e171936d0eac0ff
https://doi.org/10.1200/jco.2011.29.4_suppl.242
https://doi.org/10.1200/jco.2011.29.4_suppl.242